Anagliptin Uses, Dosage, Side Effects and more
Anagliptin is under investigation for the treatment of LDL Cholesterol, Coronary Disease, Diabetes Mellitus, Glycosylated Hemoglobin, and Dipeptidyl-Peptidase 4 Inhibitors.
| Attribute | Details |
|---|---|
| Trade Name | Anagliptin |
| Generic | Anagliptin |
| Anagliptin Other Names | Anagliptin |
| Type | |
| Formula | C19H25N7O2 |
| Weight | Average: 383.456 Monoisotopic: 383.206973073 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
